SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-055584
Filing Date
2021-04-27
Accepted
2021-04-27 16:04:28
Documents
13
Period of Report
2021-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114301d1_8k.htm   iXBRL 8-K 25890
2 EXHIBIT 99.1 tm2114301d1_ex99-1.htm EX-99.1 9578
  Complete submission text file 0001104659-21-055584.txt   213553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20210422.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20210422_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20210422_pre.xml EX-101.PRE 22711
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2114301d1_8k_htm.xml XML 3606
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 21858884
SIC: 2834 Pharmaceutical Preparations